Skip to content. Skip to navigation
Sections
Personal tools
You are here: Home Alchemist The Alchemist Newsletter: August 5, 2004
Document Actions

The Alchemist Newsletter: August 5, 2004

by chemweb last modified 03-20-09 08:07 AM
The Alchemist Newsletter Logo
Aug 5, 2004
 

The Alchemist Newsletter is back from a well deserved vacation and a move from London to Los Angeles. Now published by ChemIndustry, the newsletter and ChemWeb site will continue to be offered as a free services. We are working on some exciting new features for both the ChemIndustry and ChemWeb sites and will notify our users by email in the weeks to come. Contact us at Editor@ChemWeb.com with your comments and suggestions.

This week we begin with our bi-weekly tour of the latest chemical news. David Bradley unearths the latest on the origins of homochirality and the origins of life, the race against osteoporosis, and the failings of ionic liquids, according to the pharmaceutical industry. He also finds hot stories on a revolutionary electronic approach to studying the surfaces of technologically important materials and sees the new emergence of a new attitude toward drug discovery.

  organic: You've got to hand it to the chemists
  inorganic: Ionic liquids: information lacking
  physical: Snapshot surface chemistry
  pharma: Designer drugs
  organic: Water-borne solution to osteoporosis


You've got to hand it to the chemists

The origin of chiral asymmetry, or homochirality, in nature has been a long-standing puzzle in science. Why are almost all amino acids in nature left handed and almost all sugars right handed, for instance? Now, a team at Imperial College London have discovered that amino acids themselves may have been the amplifying molecules that tipped the balance in the early stages of life. Donna Blackmond and her colleagues measured the rates of reactions catalysed by the amino acid proline. Using sensitive calorimetry techniques they observed an enantiomeric excess even without any chiral bias in the reaction. The excess was only small but might have been enough in pre-biotic conditions to push nature one way and not the other.

How left-handed amino acids got ahead

back to top



Ionic liquids: information lacking

A great deal more research into the so-called "green" solvents known as ionic liquids must be undertaken before companies like pharmaceutical giant GlaxoSmithkline would adopt them in preference to conventional volatile organic solvents. According to Alan Curzons of GSK's corporate environment, health and safety department speaking at the RSC's Ionic Liquids conference in London, more data is needed on the properties and benefits of using ionic liquid solvents over VOCs. He reckons progress in the field is too slow and that ionic liquids are unlikely to find a place in the industry within the next ten years at the present rate of research.

Ionic liquids: what the Heck is the promise?

back to top



Snapshot surface chemistry

Ahmed Zewail and his colleagues at California Institute of Technology have developed a new ultrafast electron crystallography (UEC) technique for studying the surfaces of technologically important materials such as gallium arsenide. The crystallographic technique based on the diffraction of electrons rather than the more traditional X-ray, allows them to observe changes on a surface "frame-by-frame". UEC provides unprecedented atomic-scale resolution of surface dynamic. "We believe that UEC is now poised for many applications in the general area of surface science, nanometer-scale materials, and macromolecular structures," Zewail told X-factors webzine.

Frame by frame diffraction

back to top



Designer drugs

Seth Cohen of the University of California at San Francisco and his team have used a new type of computer model to design inhibitors for enzymes involved in diseases as diverse as cancer, arthritis, and heart disease. They say the new inhibitors should lack the problems that have plagued previous generations of inhibitors for these enzymes, such as toxicity, lack of oral availability, and rapid metabolism. Cohen's team tested eleven diverse compounds against a matrix metalloprotease enzyme and then used the results to fit the compounds to a new computer model of the enzyme's metal-containing active site. Cohen says the research is the first to use such an approach to modeling so aggressively and could lead to highly specific inhibitors for any one of the 26 MMP enzymes in the human body.

UCSD Chemists Bring Use Of Designer Molecules To Treat Common Diseases Closer To Reality

back to top



Water-borne solution to osteoporosis

Forty-one steps and a yield of just 3.5% may not sound too impressive a total synthesis but it has taken chemists almost ten years to reconstruct the complex heptacyclic marine alkaloid, norzoanthamine, first extracted from the sea anemone <i>Zoanthus sp.</i> Masaaki Miyashita's team at Hokkaido University in Japan were first past the post in an international race to synthesise the molecule. The prize could be a new treatment for osteoporosis as norzoanthamine has promising biological activity against the bone-destroying disease in animal models.

Marine alkaloid total synthesis

--David Bradley Science Writer

back to top

 
SPONSORED BY

Malvern Instruments Ltd.

Malvern Instruments is a leading, worldwide supplier of solutions for particle characterization in the laboratory and process areas. Our product range includes particle size, particle shape, and zeta potential analyzers, and high sensitivity products for screening of proteins. http://www.malvern.co.uk


Free Access to Selected CAS Science Spotlight Key Articles

 Now you can enjoy free access to some of Elsevier's most cited or most requested articles, as recognized by CAS Science Spotlight* Includes access to the #1 most requested article on CAS

For more information
click here


Technical Updates from Dow Corning

Dow Corning helps you stay on top of fast changing technologies with convenient and free e-mail updates. Featuring the latest news in silicone technology, the updates are customizable, meaning you receive high value content that's relevant to your industry and focused on your specific needs. From news, product introductions and application tips, through to trend analysis and online seminars, the e-mail updates give you access to industry leading knowledge-and at no cost to you. Get your business on the inside track, sign up now!

For more information click here.

 
   

The Alchemist is published under the copyright of ChemIndustry.com Inc.©2004. For additional information including contact information and sponsorship opportunities, please contact Rick Whiteman <Rick@ChemWeb.com> or visit our web sites at www.chemweb.com and www.chemindustry.com.

Sponsors
Web Search
 

Powered by Plone CMS, the Open Source Content Management System

This site conforms to the following standards: